Recent

% | $
Quotes you view appear here for quick access.

Talon Therapeutics, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dinepat203 dinepat203 Feb 27, 2012 5:13 PM Flag

    ODAC Meeting objective

    The committee will discuss New Drug Application (NDA) 202497, with the proposed trade name Marqibo (vincristine sulfate liposomes injection), application submitted by Talon Therapeutics, Incorporated. The proposed indication (use) for this product is for the treatment of adult patients with Philadelphia Chromosome-negative (Ph-) acute lymphoblastic leukemia (ALL) in second or greater relapse or whose disease has progressed following two or more treatment lines of anti-leukemia therapy.

    http://www.fda.gov/AdvisoryCommittees/Calendar/ucm290531.htm